Insulin delivery in T1DM: Continuous subcutaneous drip vs multiple daily shot
08 Feb 2020
byJairia Dela Cruz
Adults with type 1 diabetes mellitus (T1DM) may fare better with continuous subcutaneous insulin infusion (CSII) therapy, which is associated with lower glycated haemoglobin (HbA1c) variability compared with multiple daily injection (MDI) treatment, as shown in a recent study.